More articles from Drug Discovery and Translational Medicine

You have access
Identification of Glucose Transport Modulators In Vitro and Method for Their Deep Learning Neural Network Behavioral Evaluation in Glucose Transporter 1–Deficient Mice
Gauri Kathote, Qian Ma, Gustavo Angulo, Hong Chen, Vikram Jakkamsetti, Aksharkumar Dobariya, Levi B. Good, Bruce Posner, Jason Y. Park and Juan M. Pascual

Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 393-405; DOI: https://doi.org/10.1124/jpet.122.001428
Open Access
Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition
Irmgard Hofmann, Anke Baum, Marco H. Hofmann, Francesca Trapani, Claudia Reichel-Voda, Diane Ehrensperger, Martin Aichinger, Florian Ebner, Nicole Budano, Norbert Schweifer, Martina Sykora, Erik Depla, Joachim Boucneau, Andreas Gschwind, Norbert Kraut, Frank Hilberg and Klaus-Peter Künkele

Journal of Pharmacology and Experimental Therapeutics March 2023, 384 (3) 331-342; DOI: https://doi.org/10.1124/jpet.122.001255
Open Access
Translational PK/PD Modeling of Tumor Growth Inhibition and Target Inhibition to Support Dose Range Selection of the LMP7 Inhibitor M3258 in Relapsed/Refractory Multiple Myeloma
Floriane Lignet, Christina Esdar, Gina Walter-Bausch, Manja Friese-Hamim, Sofia Stinchi, Elise Drouin, Samer El Bawab, Andreas D. Becker, Claude Gimmi, Michael P. Sanderson and Felix Rohdich

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 163-172; DOI: https://doi.org/10.1124/jpet.122.001355
You have access
Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications
Shiva Hadi Esfahani, Srinidhi Jayaraman and Vardan T. Karamyan

Journal of Pharmacology and Experimental Therapeutics November 2022, 383 (2) 149-156; DOI: https://doi.org/10.1124/jpet.122.001339
You have access
A Novel Truncated Liver Enriched Antimicrobial Peptide-2 Palmitoylated at its N-Terminal Antagonizes Effects of Ghrelin
Lucie Holá, Blanka Železná, Alena Karnošová, Jaroslav Kuneš, Jean-Alain Fehrentz, Séverine Denoyelle, Sonia Cantel, Miroslava Blechová, David Sýkora, Aneta Myšková and Lenka Maletínská

Journal of Pharmacology and Experimental Therapeutics November 2022, 383 (2) 129-136; DOI: https://doi.org/10.1124/jpet.122.001322
Open Access
Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A
Antonietta Franco, Xiawei Dang, Lihong Zhang, Perry B. Molinoff and Gerald W. Dorn

Journal of Pharmacology and Experimental Therapeutics November 2022, 383 (2) 137-148; DOI: https://doi.org/10.1124/jpet.122.001332
Open Access
Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia
Anna Zuk, Zhihai Si, Sally Loi, Santhosh Bommegowda, Debie Hoivik, Sanjay Danthi, Gyongyi Molnar, Vilmos Csizmadia and Michael Rabinowitz

Journal of Pharmacology and Experimental Therapeutics October 2022, 383 (1) 11-24; DOI: https://doi.org/10.1124/jpet.122.001126
You have access
Effect of Novel Biotherapeutic Elevating Angiopoietin 1 on Progression of Diabetic Nephropathy in Diabetic/Obese Mice
Peng Sun, Christina S. Bartlett, Chao Zheng, Tammy Bigwarfe, Joshuaine M. Grant, Margit MacDougall, Valentina Berger, Steven Kerr, Hu Sheng Qian, Mark McHugh, Hongxing Chen, Xiaomei Zhang, Miranda L. Carpenter, Heather N. Robinson, John Miglietta, Thorsten Lamla and Ryan M. Fryer

Journal of Pharmacology and Experimental Therapeutics September 2022, 382 (3) 266-276; DOI: https://doi.org/10.1124/jpet.121.001067
Open Access
Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB
N. Matthew Ellinwood, Bethann N. Valentine, Andrew S. Hess, Jackie K. Jens, Elizabeth M. Snella, Maryam Jamil, Shannon J. Hostetter, Nicholas D. Jeffery, Jodi D. Smith, Suzanne T. Millman, Rebecca L. Parsons, Mark T. Butt, Sundeep Chandra, Martin T. Egeland, Ana B. Assis, Hemanth R. Nelvagal, Jonathan D. Cooper, Igor Nestrasil, Bryon A. Mueller, Rene Labounek, Amy Paulson, Heather Prill, Xiao Ying Liu, Huiyu Zhou, Roger Lawrence, Brett E. Crawford, Anita Grover, Ganesh Cherala, Andrew C. Melton, Anu Cherukuri, Brian R. Vuillemenot, Jill C.M. Wait, Charles A. O’Neill, Jason Pinkstaff, Joseph Kovalchin, Eric Zanelli and Emma McCullagh

Journal of Pharmacology and Experimental Therapeutics September 2022, 382 (3) 277-286; DOI: https://doi.org/10.1124/jpet.122.001119
Open Access
Beneficial Effects of the Direct AMP-Kinase Activator PXL770 in In Vitro and In Vivo Models of X-Linked Adrenoleukodystrophy
Pierre-Axel Monternier, Parveen Parasar, Pierre Theurey, Pascale Gluais Dagorn, Navtej Kaur, Tavarekere N Nagaraja, Pascale Fouqueray, Sébastien Bolze, David E. Moller, Jaspreet Singh and Sophie Hallakou-Bozec

Journal of Pharmacology and Experimental Therapeutics August 2022, 382 (2) 208-222; DOI: https://doi.org/10.1124/jpet.122.001208

Main menu

User menu

Search

More articles from Drug Discovery and Translational Medicine

Pages

Navigate

More Information

ASPET's Other Journals